Tuesday, 19 January 2027, 18:30
Lecture with Max Wolff
The Case for Considering Psychedelics as Psychotherapeutic Tools
Psychedelic treatments are increasingly seen as drug-based interventions, with psychotherapy as a mere add-on. Drawing on a large psilocybin trial for depression, Max Wolff argues that the therapeutic relationship and psychotherapeutic processes are central to treatment success – and that psychedelics may be better understood as tools for psychotherapy.
About the speaker
Max Wolff is a psychologist, psychotherapist and clinician-scientist at Humboldt University Berlin, Germany. His research bridges psychedelic and psychotherapy research and explores psychological change processes associated with altered states of consciousness. He has contributed as a researcher and therapist to several clinical trials in the field and is committed to advancing professional training programs in psychedelic therapy.
Further reading
Live on Zoom only – there will be no recording this time.
Date: Tuesday, 19 January 2027, 18:30
Location: Online via Zoom
In cooperation with the Berlin Psychedelic Science Association
A joint lecture by the PSNG and the BPSA.




















































